Skip navigation.

Welcome to SAfAIDS

SAfAIDS news

Atripla three times weekly maintains HIV viral suppression for 24 weeks

UNIVERSITY OF BARCELONA, 05 July 2016 (aidsmap) - People with undetectable viral load who switched from taking the Atripla single-tablet regimen (efavirenz/tenofovir/emtricitabine) every day to just every other weekday were able to maintain viral suppression for six months, and longer follow-up is planned, according to research presented last month at the ASM Microbe conference in Boston.

Why is tackling stigma so difficult?

UK, 04 July 2016, (nat) - For many in HIV advocacy addressing stigma is the Holy Grail. Many, if not all, of the factors that drive the HIV epidemic are embroiled with stigma.  The impact it has on the lives of people living with HIV is well documented.  In a recent survey of over half of people living with HIV reported feelings of shame, guilt, low self-esteem and self-blame; one in five had experienced verbal harassment or threats.

HPV cervical cancer test introduced in England

ENGLAND, 04 July 2016 (bbcnews) - The NHS in England is introducing a "superior" test for cervical cancer, following a successful pilot programme.

Women in HIV serodiscordant relationships less likely to take PrEP consistently if they experience intimate partner violence

BOSTON, 30 June 2016 (aidsmap) - Experiencing intimate partner violence is associated with an increased risk of poor adherence to HIV pre-exposure prophylaxis (PrEP) among women in serodiscorant relationships in sub-Saharan Africa, investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Overall, 16% of women experienced intimate partner violence (IPV) and this increased the risk of suboptimal adherence to PrEP by 50%, when measured by either pill count or plasma tenofovir concentrations.

New effort uses implementation science to reduce mother-to-child HIV transmission Studies investigate best practices to ease HIV disease burden in Sub-Saharan Africa

FOGARTY INTERNATIONAL CENTRE, 30 June 2016 (sciencedaily) - An emerging field, known as implementation science, may help reduce the nearly 150,000 instances of mother-to-child HIV transmissions that occur annually around the world, mostly in developing countries. A team of scientists and program managers, led by the National Institutes of Health, has been studying a variety of implementation science approaches to prevent mother-to-child transmission and has published the results in a 16-article open-access supplement to the Journal of Acquired Immune Deficiency Syndromes. In implementation science, scientists study how to integrate research findings and other evidence-based practices into routine care and services

Shape-changing enzyme suggests how small doses of anti-HIV drug might treat Alzheimer's

NIST, 28 June 2016 (sciencedaily) - Molecular roadmap provides key evidence supporting proposal to launch clinical trials of efavirenz as an Alzheimer's treatment


at the site shown in orange, it increases the flexibility of the protein in the region (magenta) around cholesterol (green). Regions with no changes are shown in grey and iron-containing heme in black.


Syndicate content